Effect evaluation of quality control circle on shortening DNT in patients with cerebral ischemic stroke
- VernacularTitle:品管圈对缩短急性缺血性脑卒中患者DNT的效果评价
- Author:
Ruili LI
1
;
Jianping ZHAO
;
Wanhong WEI
;
Fangfang MA
;
Min GUO
Author Information
1. 河南省荥阳市人民医院神经内科
- Keywords:
QCC;
Cerebral ischemic stroke;
DNT
- From:
China Modern Doctor
2018;56(13):134-136,141
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the application effect of the quality control circle(QCC) on shortening DNT in patients with cerebral ischemic stroke. Methods QCC activity group had been established and the reasons for the DNT extension in patients with cerebral ischemic stroke were analyzed so as to identify key improvement links and to formulate and to implement countermeasures. Fifteen cases with cerebral ischemic stroke in our hospital before the implementation of QCC from March to April in 2016 were selected as the control group, and 32 cases of patients with cerebral ischemic stroke after the implementation of QCC activities from May to August in 2016 were selected as the observation group. DNT in the two groups of thrombolytic cases were compared, and the more time consuming of emergency, blood test and signature communication were compared and optimized. Results The average DNT of patients with acute cerebral stroke in the observation group was significantly shorter than that in the control group, and the difference was statistically significant (P＜0. 05). There were 5 cases with more than 110min DNT in the control group and no case with more than 110min DNT in the observation group, and the difference was statistically significant (P＜0. 05). The average time consuming in emergency treatment, blood specimen test and signature communication in the observation group was significantly shorter than that in the control group, and the differences were statistically significant(P＜0. 05). Conclusion Through the implementation of QCC can effectively regulate the emergency treatment process of stroke and shorten the DNT in patients with cerebral ischemic diseases.
